Sinovac Biotech (FRA:SVQ) Accounts Payable & Accrued Expense : €957.6 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sinovac Biotech Accounts Payable & Accrued Expense?

Sinovac Biotech's quarterly accounts payable & accrued expense declined from Dec. 2022 (€989.2 Mil) to Jun. 2023 (€885.2 Mil) but then increased from Jun. 2023 (€885.2 Mil) to Dec. 2023 (€957.6 Mil).

Sinovac Biotech's annual accounts payable & accrued expense declined from Dec. 2021 (€2,040.2 Mil) to Dec. 2022 (€989.2 Mil) and declined from Dec. 2022 (€989.2 Mil) to Dec. 2023 (€957.6 Mil).

Sinovac Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sinovac Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinovac Biotech Accounts Payable & Accrued Expense Chart

Sinovac Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

59.33

211.94

2,040.17

989.23

957.62

Sinovac Biotech Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,040.17	485.22	989.23	885.23	957.62

Sinovac Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sinovac Biotech (FRA:SVQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinovac Biotech Ltd (FRA:SVQ) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085

Website

http://www.sinovac.com

Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.

Sinovac Biotech (FRA:SVQ) Headlines

No Headlines